로딩 중…
지수 로딩 중…
Tectonic Therapeutic, Inc.
TECX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$27.92-0.39%
2026-08-03
Financials
Valuation Metrics
Tectonic Therapeutic, Inc.'s Market Cap is $527M. At end of 2025 it was $382M. Ranked #2779 of 3,112 in US market (top 89%), #1204 of 1,445 on NASDAQ (top 83%), #221 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 82%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $527M | US#2,779/3,112 Sec#221/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-83M | US—/3,112 Sec—/269 |
| Total Assets | $247M | US#2,945/3,112 Sec#235/269 |
| Net Assets | $230M | US#2,683/3,112 Sec#186/269 |
| Value | ||
| P/B | 2.29x | US#1,355/3,112 Sec#62/269 |
| FCF Yield | -12.46% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -36.23% | US#2,669/3,112 Sec#142/269 |
| ROA | -33.86% | US#2,893/3,112 Sec#171/269 |
| Financial Health | ||
| Debt Ratio | 7.01% | US#69/3,112 Sec#32/269 |
| Total Debt | $5M | US#2,855/3,112 Sec#218/269 |
| FCF | $-66M | US#2,511/3,112 Sec#123/269 |
| Cash | $237M | US#1,598/3,112 Sec#100/269 |
| Current Ratio | 18.51x | US#132/3,112 Sec#36/269 |
| Performance | ||
| 1Y Return | 34.68% | US#1,151/3,112 Sec#141/269 |
| 1M Return | -26.39% | US#3,036/3,112 Sec#249/269 |
| From 52W High | -29.37% | US#2,148/3,112 Sec#161/269 |
| 1Y MDD | -44.62% | US#2,190/3,112 Sec#166/269 |
| Trading | ||
| Volume | 103,306 shares | US#2,930/3,112 Sec#263/269 |
| Trading Value | $3M | US#2,832/3,112 Sec#235/269 |
| Per Share | ||
| EPS | $-4.05 | US—/3,112 Sec—/269 |
| BPS | $13.72 | US#1,542/3,112 Sec#48/269 |